Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This completed Phase 1 trial assessed a radiolabeled monoclonal antibody therapy in combination with chemotherapy and bevacizumab for metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Combination chemotherapy
• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Status: COMPLETED